$636Million– No. of Holdings #44
Octagon Capital Advisors LP has about 74.1% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 74.1 |
Others | 25.9 |
Octagon Capital Advisors LP has about 7.2% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 32.5 |
UNALLOCATED | 26 |
SMALL-CAP | 23.8 |
MICRO-CAP | 9.8 |
LARGE-CAP | 7.2 |
About 32.9% of the stocks held by Octagon Capital Advisors LP either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
Others | 67.1 |
RUSSELL 2000 | 32.9 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Octagon Capital Advisors LP has 44 stocks in it's portfolio. About 64% of the portfolio is in top 10 stocks. APLS proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Octagon Capital Advisors LP last quarter.
Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ACET | adicet bio inc | 0.15 | 767,799 | 929,037 | unchanged | 0.00 | ||
AKRO | akero therapeutics inc | 1.04 | 283,372 | 6,647,910 | reduced | -16.66 | ||
ALLO | allogene therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ALVR | allovir inc | 1.11 | 9,800,000 | 7,088,340 | added | 133 | ||
ANAB | anaptysbio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ANNX | annexon inc | 0.31 | 400,000 | 1,960,000 | reduced | -80.49 | ||
ANTX | an2 therapeutics inc | 1.09 | 3,220,260 | 6,923,560 | added | 191 | ||
APLS | apellis pharmaceuticals inc | 17.37 | 2,880,880 | 110,511,000 | added | 2.63 | ||
ARWR | arrowhead pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AUTL | autolus therapeutics plc | 0.10 | 176,000 | 612,480 | unchanged | 0.00 | ||
AVTE | aerovate therapeutics inc | 0.12 | 465,440 | 772,630 | added | 15.3 | ||
BBIO | bridgebio pharma inc | 2.75 | 690,000 | 17,477,700 | unchanged | 0.00 | ||
CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
CNTA | centessa pharmaceuticals plc | 3.33 | 2,345,080 | 21,176,000 | added | 13.83 | ||
CRBP | corbus pharmaceuticals hldgs | 3.47 | 488,000 | 22,082,000 | added | 20.49 | ||
CYBN | cybin inc | 0.79 | 18,604,600 | 5,041,860 | unchanged | 0.00 | ||
CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
DYN | dyne therapeutics inc | 6.55 | 1,180,800 | 41,670,400 | reduced | -5.00 | ||
ELEV | elevation oncology inc | 0.32 | 747,000 | 2,016,900 | new | |||